Abstract
The combination of heparin and aspirin is widely regarded as 'standard therapy' to increase rates of live birth in patients with recurrent pregnancy loss and positive antiphospholipid antibodies. However, this recommendation is based largely on expert opinion. Does a meta-analysis of randomized controlled trials support the practice?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
